1. Scrip
  2. >>R&D

Pharma Could Do Better With Data, Say IBM, McLaren

 
• By Kevin Grogan

The great and good of the pharmaceutical industry have again been speaking about the big opportunities that big data provides, but senior executives from IBM Watson Health and Formula 1 giant McLaren believe the sector should be doing more.

F1
F1 Urges Pharma To Accelerate Data Strategies • Source: Shutterstock

A sizeable chunk of the European Federation of Pharmaceutical Industries and Associations’ annual conference in Brussels was dedicated to discussing the volumes of data being produced and what can be done with it. Stefan Oschmann, chief executive at Merck KGAA and newly-appointed EFPIA president, noted that the advances in digital technology as well as big data “will help us to unlock tomorrow’s cures across Europe”. However, senior executives in attendance from IBM Watson Health and McLaren Applied Technologies said the pharma industry needs to do more.

Mr Oschmann said that “realizing the potential of health data in shaping patient care and driving research” will be a...

More from R&D

More from Scrip

Syncona Looks To Go Private As Market Decline Deepens

 
• By Andrew McConaghie

While some are calling for Syncona to be wound up, the UK-based company believes many existing and new investors will back the creation of new private fund.

Gilead’s Yeztugo Gets US Approval For Twice-Yearly PrEP

 
• By Alexandra Shimmings

The first twice-yearly option for HIV prevention has been approved by the US Food and Drug Administration in an advance that “brings us closer than ever to ending the HIV epidemic,” said CEO Daniel O’Day.

ASCO: Pushing The Frontiers Of ADCs

 
• By Mary Jo Laffler

Antibody-drug conjugates are a major part of the oncology pipeline, and data presented at the American Society of Clinical Oncology meeting highlight the emergence of new technologies.